Skip to main content
Premium Trial:

Request an Annual Quote

Sumitomo to Acquire Life Sciences VC Oxford Finance

NEW YORK, Jan. 30 (GenomeWeb News) - Oxford Finance, which has backed several genomics companies, is slated to be acquired by Sumitomo of Japan, the companies said yesterday.


Oxford, privately held and based in Alexandria, Va., has provided financing to several life sciences tools companies, including US Genomics, Structural Genomix, and Cellular Genomics. The company said its has a total of 50 active portfolio companies.


If the deal closes, Sumitomo America will acquire all of Oxford's assets for $51 million plus the assumption of certain liabilities related to its businesses, Oxford said.


Sumitomo said it believes the transaction will enable Oxford to triple its portfolio in the net three years and offer its clients and venture capitalists increased access to the Japanese life sciences community, as well as expand its client base and line of products.




The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.